Follow
Daria Artamonova
Daria Artamonova
Other namesDaria Vorontsova
Unknown affiliation
Verified email at skoltech.ru
Title
Cited by
Cited by
Year
Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2
AW Kasumu, C Hougaard, F Rode, TA Jacobsen, JM Sabatier, BL Eriksen, ...
Chemistry & biology 19 (10), 1340-1353, 2012
1712012
Structure studies of the CRISPR-Csm complex reveal mechanism of co-transcriptional interference
L You, J Ma, J Wang, D Artamonova, M Wang, L Liu, H Xiang, ...
Cell 176 (1), 239-253. e16, 2019
1392019
Chronic suppression of inositol 1, 4, 5-triphosphate receptor-mediated calcium signaling in cerebellar purkinje cells alleviates pathological phenotype in spinocerebellar …
AW Kasumu, X Liang, P Egorova, D Vorontsova, I Bezprozvanny
Journal of Neuroscience 32 (37), 12786-12796, 2012
1292012
Foreign DNA acquisition by the IF CRISPR–Cas system requires all components of the interference machinery
D Vorontsova, KA Datsenko, S Medvedeva, J Bondy-Denomy, ...
Nucleic acids research 43 (22), 10848-10860, 2015
1042015
Highly efficient primed spacer acquisition from targets destroyed by the Escherichia coli type IE CRISPR-Cas interfering complex
E Semenova, E Savitskaya, O Musharova, A Strotskaya, D Vorontsova, ...
Proceedings of the National Academy of Sciences 113 (27), 7626-7631, 2016
1032016
Type III CRISPR-Cas systems: deciphering the most complex prokaryotic immune system
MV Kolesnik, I Fedorova, KA Karneyeva, DN Artamonova, KV Severinov
Biochemistry (Moscow) 86, 1301-1314, 2021
412021
Spacer acquisition by Type III CRISPR–Cas system during bacteriophage infection of Thermus thermophilus
D Artamonova, K Karneyeva, S Medvedeva, E Klimuk, M Kolesnik, ...
Nucleic Acids Research 48 (17), 9787-9803, 2020
292020
Natural diversity of CRISPR spacers of Thermus: evidence of local spacer acquisition and global spacer exchange
A Lopatina, S Medvedeva, D Artamonova, M Kolesnik, V Sitnik, ...
Philosophical Transactions of the Royal Society B 374 (1772), 20180092, 2019
292019
PpCas9 from Pasteurella pneumotropica — a compact Type II-C Cas9 ortholog active in human cells
I Fedorova, A Vasileva, P Selkova, M Abramova, A Arseniev, G Pobegalov, ...
Nucleic acids research 48 (21), 12297-12309, 2020
252020
DNA targeting by Clostridium cellulolyticum CRISPR–Cas9 Type II-C system
I Fedorova, A Arseniev, P Selkova, G Pobegalov, I Goryanin, A Vasileva, ...
Nucleic acids research 48 (4), 2026-2034, 2020
242020
Polyclonal antibodies against human proteasome subunits PSMA3, PSMA5, and PSMB5
VA Livinskaya, VA Ivanov, OA Fedorova, DN Vorontsova, NA Barlev, ...
Hybridoma 31 (4), 272-278, 2012
92012
Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilus
K Karneyeva, M Kolesnik, A Livenskyi, V Zgoda, V Zubarev, A Trofimova, ...
Journal of molecular biology 436 (6), 168448, 2024
12024
Use of cas9 protein from the bacterium pasteurella pneumotropica
KV Severinov, SA Shmakov, DN Artamonova, II Goryanin, OS Musharova, ...
US Patent App. 17/775,626, 2022
2022
Dna-cutting agent based on cas9 protein from the bacterium pasteurella pneumotropica
KV Severinov, SA Shmakov, DN Artamonova, II Goryanin, OS Musharova, ...
US Patent App. 17/617,039, 2022
2022
Dna cutting means based on cas9 protein from defluviimonas sp.
KV Severinov, SA Shmakov, DN Artamonova, II Goryanin, OS Musharova, ...
US Patent App. 17/296,629, 2022
2022
DNA cutting means based on Cas9 protein from biotechnologically significant bacterium Clostridium cellulolyticum
KV Severinov, SA Shmakov, DN Artamonova, II Goryanin, OS Musharova, ...
US Patent App. 17/296,597, 2022
2022
Pasteurella pneumotropica and Demequina sediminicola Cas9 orthologs characterization
A Vasileva, O Musharova, G Pobegalov, D Artamonova, I Fedorova, ...
FEBS OPEN BIO 9, 398-398, 2019
2019
Natural diversity of CRISPR spacers of Thermus
A Lopatina, S Medvedeva, D Artamonova, M Kolesnik, V Sitnik, ...
Philosophical Transactions: Biological Sciences 374 (1772), 1-10, 2019
2019
Adaptation By T. Thermophilus Type III CRISPR-Cas System in the Presence of Different Phages and Appearance of Viral Escapes
D Artamonova, K Karneyeva, K Severinov, A Yasinskaya, A Milenkin
3rd International Conference on CRISPR Technologies 2019, 64-65, 2019
2019
COMPARATIVE ANALYSIS OF THE ACTION OF EUBACTERIAL CLASS 1 CRISPR-CAS SYSTEMS
DN ARTAMONOVA
2017
The system can't perform the operation now. Try again later.
Articles 1–20